IBCN 2024 REMINDER: The deadline for abstract submission is rapidly approaching! Abstracts must be submitted by May 31st. ibcnweb.com/abstracts/

Roland Seiler-Blarer
Peter Black
Tilman Todenhöfer
Kent Mouw
Lars Dyrskjøt
@JeffreyD_UNC

📝📍finally out the first recommendations paper from the #GURetreat Ospedale San Raffaele Optimizing the use of NGS in pts with UC| Valentina Tateo Antonio Cigliola Chiara Mercinelli Neeraj Agarwal, MD, FASCO Petros Grivas Ashish M. Kamat, MD, MBBS Lars Dyrskjøt ylt Shilpa Gupta Philippe spiess clinical-genitourinary-cancer.com/article/S1558-…

Save the dates: 29th & 30th May 2025.

#EAU24 European Association of Urology (EAU) BAUS BSoT BURST Urology Amer. Urol. Assn. World Bladder Cancer Patient Coalition

Come to #Edinburgh

Come to #Scotland

12th Scottish #BladderCancer Symposium - High Risk NMIBC & MIBC.

Some of the faculty:

Join us September 19-21, 2024 in Bern, Switzerland for the IBCN Annual Meeting. See below for an amazing lineup of topics and speakers!!! Abstract deadline May 31st!! Roland Seiler-Blarer Peter Black Tilman Todenhöfer Kent Mouw Lars Dyrskjøt

Not too late to register for the 6th Annual Bladder Translational Meeting - always a high quality event! kcl.ac.uk/events/6th-bla…

We are excited to announce that meeting registration and abstract submission for the 2024 IBCN Annual Meeting in Bern, Switzerland is now OPEN! Please visit ibcnweb.com for all the details. #IBCN2024 Peter Black Tilman Todenhöfer Roland Seiler-Blarer Lars Dyrskjøt Kent Mouw

Submit an abstract by February 27 for the AACR Special Conference on Bladder Cancer (May 17-20, Charlotte, NC), chaired by Lars Dyrskjøt, Donna Hansel MD, PhD, Dan Theodorescu, and Tahlita C. M. Zuiverloon. Learn more:
bit.ly/3wh0DhC
#AACRbladder24 Lars Dyrskjøt Tahlita Zuiverloon MD PhD

It was great to see you here in Aarhus Madhuri Madhuri Koti - thanks for spending time with us and for great discussions with Sia and the rest of the team. And congratulations again to Sia Viborg Lindskrog on a successful PhD thesis defense 🏆👏
Dept. of Molecular Medicine Aarhus Universitet

Urinary biomarkers for bladder cancer have come a long way, but several caveats limit use.

Is urinary tumor DNA the way of the future? We think so! Read this 👇

European Urology Roger Li
Joshua Meeks Lars Dyrskjøt

authors.elsevier.com/c/1iUcz_6tuN-h…

Submit an abstract by February 27 for the AACR Special Conference on Bladder Cancer (May 17-20, Charlotte, NC), chaired by Lars Dyrskjøt, Donna Hansel MD, PhD, Dan Theodorescu, and Tahlita C. M. Zuiverloon. Learn more:
bit.ly/3NN6SiW
#AACRbladder24 Lars Dyrskjøt Tahlita Zuiverloon MD PhD

AACR special conference on bladder cancer. I hope to see many of you in Charlotte 17-20 May 2024. Mark you calendars now - we have a strong speaker lineup already

Dan Theodorescu Donna Hansel MD, PhD Tahlita Zuiverloon MD PhD AACR

aacr.org/meeting/aacr-s…

I enjoyed attending the bladder cancer course in Paris this week. Thanks for the invitation Yves Allory François Radvanyi and Isabelle Bernard-Pierrot Institut Curie.

👁️ Highlights from Yves Allory Institut Curie

1️⃣ Pathological response & survival correlation in NAC ♻️
2️⃣ Intratumoral heterogeneity's 🧩 influence on prognosis
3️⃣ VESPER trial insights on molecular subtypes 📊

#UrothelialCancersCourse2023 #Day2 #urology #MIBC #bladdercancer

Thanks for taking the time to visit us here in Aarhus, Kent Kent Mouw. It was great to see you 😎

It was great to see you all in Milan for the #GURetreat23 . Congrats Andrea Necchi and team for a successful meeting Petros Grivas Neeraj Agarwal, MD, FASCO Philippe spiess Ewan Gibb

BIOMARKERS FOR RENAL CANCER NEEDED
In our recent review in Clinical Cancer Research we describe the current clinical needs for biomarkers in patients with #renalcancer care, and discuss the challenges of biomarker development.

aacrjournals.org/clincancerres/…

Great overview of molecular subtypes and clinical potential in MIBC by Ewan Gibb #GURetreat23

On my way to Milano to attend this exiting action packed program planned by Andrea Necchi and team - looking forward to great science discussions with friends and colleagues #GURetreat23

great paper evaluating cTDNA LONG TERM role post +/- NAC and cystectomy of 68 NAC and 102 NAC Naive patients by Lars Dyrskjøt ... lets summarize Clinical Cancer Research Bladder Cancer Advocacy Network

Our NEW Primer on Bladder cancer is live today! By Lars Dyrskjøt, Hansel, Efstathiou, Knowles, Matt Galsky, Jeremy Teoh & Dan Theodorescu.

Check it out here:
go.nature.com/3FxR0MF